Praetorian Acquisition Corp Class A PTOR
About Quantitative Ratings
Morningstar Quantitative Ratings for Stocks are generated using an algorithm that compares companies that are not under analyst coverage to peer companies that do receive analyst-driven ratings. Companies with quantitative ratings are not formally covered by a Morningstar analyst, but are statistically matched to analyst-rated companies, allowing our models to calculate a quantitative moat, fair value, and uncertainty rating.
Trading Information
- Previous Close Price
- $0.00
- Day Range
- $9.98–9.98
- 52-Week Range
- $0.00–10.04
- Bid/Ask
- $9.97 / $9.98
- Shares Outstanding
- 33.92M
- Market Cap
- $338.55M
- Volume/Avg
- 11,004 / 38,331
Key Statistics
- Price/Earnings (Normalized)
- —
- Price/Sales
- —
- Dividend Yield (Trailing)
- 0.00%
- Dividend Yield (Forward)
- 0.00%
- Dividend Payment Schedule
- —
- Total Yield
- —
Company Profile
Praetorian Acquisition Corp is a blank check company formed for the purpose of effecting a merger, amalgamation, share exchange, asset acquisition, share purchase, reorganization or similar business combination with one or more businesses.
- Sector
- Financial Services
- Industry
- Shell Companies
- Stock Style Box
- —
- Total Number of Employees
- —
- Website
- https://praetorianacq.com
Valuation
|
Metric
|
PTOR
|
|---|---|
Price/Earnings (Normalized) | — |
Price/Book Value | 1.35 |
Price/Sales | — |
Price/Cash Flow | — |
Price/Earnings
No chart available
Financial Strength
|
Metric
|
PTOR
|
|---|---|
Quick Ratio | 1.42 |
Current Ratio | 1.58 |
Interest Coverage | — |
Quick Ratio
PTOR
Profitability
|
Metric
|
PTOR
|
|---|---|
Return on Assets (Normalized) | — |
Return on Equity (Normalized) | — |
Return on Invested Capital (Normalized) | — |
Return on Assets
No chart available
Shell Companies Industry Comparables
|
1-Day Chart
|
Name
|
Price
|
Morningstar Rating for Stocks
|
Capital Allocation
|
Economic Moat
|
Market Cap
|
|---|---|---|---|---|---|---|
| Vylor Inc
VYLR
| LOCK|<@#m<!gr | LOCK|&&# | $47B | |||
| Drugs Made In America Acquisition II Corp
DMII
| — | LOCK|lR@B% | $649M | |||
| EQV Ventures Acquisition Corp II Class A
EVAC
| — | LOCK|!##R | $604M | |||
| Bain Capital GSS Investment Corp Class A
BCSS
| — | LOCK|dh>Qj | $596M | |||
| Cantor Equity Partners IV Inc Ordinary Shares - Class A
CEPF
| — | LOCK|DRR?R | $588M | |||
| Churchill Capital Corp XII Class A
CXII
| — | LOCK|Tv^ | $577M | |||
| Churchill Capital Corp XI Common shares class A
CCXI
| — | LOCK|g% | $572M | |||
| American Exceptionalism Acquisition Corp A Ordinary Shares-Class A
AEXA
| — | LOCK|l$$?& | $529M | |||
| New America Acquisition I Corp Class A
NWAX
| — | LOCK|dHH@ | $499M | |||
| Ares Acquisition Corp III Class A
AAC
| — | LOCK|@NzV | $492M |
United States